203 related articles for article (PubMed ID: 9925876)
1. N-linked glycosylation sites determine HERG channel surface membrane expression.
Petrecca K; Atanasiu R; Akhavan A; Shrier A
J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):41-8. PubMed ID: 9925876
[TBL] [Abstract][Full Text] [Related]
2. Role of glycosylation in cell surface expression and stability of HERG potassium channels.
Gong Q; Anderson CL; January CT; Zhou Z
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H77-84. PubMed ID: 12063277
[TBL] [Abstract][Full Text] [Related]
3. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects.
Zhou Z; Gong Q; Epstein ML; January CT
J Biol Chem; 1998 Aug; 273(33):21061-6. PubMed ID: 9694858
[TBL] [Abstract][Full Text] [Related]
4. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
[TBL] [Abstract][Full Text] [Related]
5. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
[TBL] [Abstract][Full Text] [Related]
6. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
7. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
8. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.
Roti EC; Myers CD; Ayers RA; Boatman DE; Delfosse SA; Chan EK; Ackerman MJ; January CT; Robertson GA
J Biol Chem; 2002 Dec; 277(49):47779-85. PubMed ID: 12270925
[TBL] [Abstract][Full Text] [Related]
9. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Sanguinetti MC; Jiang C; Curran ME; Keating MT
Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
[TBL] [Abstract][Full Text] [Related]
12. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
Zhou Z; Gong Q; January CT
J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2.
Cui J; Kagan A; Qin D; Mathew J; Melman YF; McDonald TV
J Biol Chem; 2001 May; 276(20):17244-51. PubMed ID: 11278781
[TBL] [Abstract][Full Text] [Related]
14. Identification of a COOH-terminal segment involved in maturation and stability of human ether-a-go-go-related gene potassium channels.
Akhavan A; Atanasiu R; Shrier A
J Biol Chem; 2003 Oct; 278(41):40105-12. PubMed ID: 12885765
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the S4-S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes.
Sanguinetti MC; Xu QP
J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):667-75. PubMed ID: 9882738
[TBL] [Abstract][Full Text] [Related]
16. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
Mbai M; Rajamani S; January CT
Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
[TBL] [Abstract][Full Text] [Related]
17. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
Paul AA; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
[TBL] [Abstract][Full Text] [Related]
19. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.
Sanguinetti MC; Curran ME; Spector PS; Keating MT
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2208-12. PubMed ID: 8700910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
